Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02ANG
|
|||
| Former ID |
DNC012508
|
|||
| Drug Name |
(2-Amino-4,5-dihydro-thiazol-4-yl)-acetic acid
|
|||
| Synonyms |
CHEMBL79325; 2-(2-Amino-2-thiazolin-4-yl)acetic acid; AC1NQ6SQ; SCHEMBL2711624; 2-(2-amino-4,5-dihydro-1,3-thiazol-4-yl)acetic Acid; ANCWBXJZUCHVHL-UHFFFAOYSA-N
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C5H8N2O2S
|
|||
| Canonical SMILES |
C1C(N=C(S1)N)CC(=O)O
|
|||
| InChI |
1S/C5H8N2O2S/c6-5-7-3(2-10-5)1-4(8)9/h3H,1-2H2,(H2,6,7)(H,8,9)
|
|||
| InChIKey |
ANCWBXJZUCHVHL-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | GABA(A) receptor alpha-1 (GABRA1) | Target Info | Inhibitor | [1] |
| Gamma-aminobutyric acid receptor (GAR) | Target Info | Inhibitor | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Retrograde endocannabinoid signaling | ||||
| GABAergic synapse | ||||
| Morphine addiction | ||||
| Nicotine addiction | ||||
| Reactome | Ligand-gated ion channel transport | |||
| GABA A receptor activation | ||||
| WikiPathways | SIDS Susceptibility Pathways | |||
| Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | ||||
| Iron uptake and transport | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ( )-2-amino-2-thiazoline-4-ethanoic acid; a novel, specific GABAA receptor agonist. Bioorg. Med. Chem. Lett. 1(5):247-248 (1991). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.